Moody Aldrich Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2M	Sell	3,829 -47	-1%	-$22.5K	0.36%	109
2025 Q4	$2.26M	Buy	+3,876	New	+$1.98M	0.42%	105
2024 Q3	–	Sell	-4,814	Closed	-$1.35M	–	207
2024 Q2	$1.35M	Sell	4,814 -310	-6%	-$73.8K	0.26%	108
2024 Q1	$1.37M	Sell	5,124 -4,099	-44%	-$966K	0.23%	115
2023 Q4	$2.13M	Sell	9,223 -4,356	-32%	-$762K	0.38%	94
2023 Q3	$1.98M	Buy	13,579 +2,653	+24%	+$499K	0.38%	89
2023 Q2	$2.52M	Buy	10,926 +3,746	+52%	+$1.01M	0.49%	82
2023 Q1	$1.74M	Buy	+7,180	New	+$1.96M	0.35%	95
2018 Q4	–	Sell	-10,467	Closed	-$2.24M	–	104
2018 Q3	$2.24M	Buy	10,467 +5,395	+106%	+$1.35M	0.65%	75
2018 Q2	$1.42M	Buy	+5,072	New	+$891K	0.5%	80